Saffron and major depressive disorder: meta-analysis of clinical trials (2013)

Re:Saffron and major depressive disorder: meta-analysis of c... by forum_ghost on Monday March 14, 2022 @06:56AM (#30670826)

This is a marketing paper.

Competing interests: Drs. Anton and Hausenblas serve as scientific advisors and as consultants for the company ReBody, LLC, which is an affiliate of Reserve Life Organics., LLC d/b/a Reserveage Organics, the developer and marketer of a product in which saffron is used.

[ Parent | on HN ]

Re:Saffron and major depressive disorder: meta-analysis of c... by noname120 on Monday March 14, 2022 @07:09AM (#30670922)

It's a meta study. There can be bias in selecting the studies, and the way they interpret the results. But it doesn't necessarily means there is, further review is needed.

[ Parent | on HN ]

Re:Saffron and major depressive disorder: meta-analysis of c... by bigDinosaur on Monday March 14, 2022 @07:17AM (#30670991)

I think the heuristic of giving this a weight of approximately zero is reasonable, since nobody here is actually going to go check out every study in the meta analysis nor is anyone here going to verify the statistics of this paper.

[ Parent | on HN ]

Re:Saffron and major depressive disorder: meta-analysis of c... by noname120 on Tuesday March 15, 2022 @07:31AM (#30684067)

Disagree. Even if there is strong selection bias, the positive evidence that they present is worth considering.

[ Parent | on HN ]